J. Enssle

发表

Receptor targeting of adeno-associated virus vectors

M. Hallek, L. Perabò, H. Büning, 2003, Gene Therapy.

Foamy Virus Particle Formation

D. Lindemann, A. Rethwilm, J. Enssle, 1998, Journal of Virology.

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display.

M. Hallek, L. Perabò, D. Kofler, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth.

P. Boekstegers, R. Bals, H. Büning, 2009, Human gene therapy.

rAAV-based gene transfer of cathelicidin induces therapeutic neovasculariziation preferentially via potent collateral growth

P. Boekstegers, R. Bals, H. Büning, 2008 .

Nuclear degradation of nonsense mutated beta-globin mRNA: a post-transcriptional mechanism to protect heterozygotes from severe clinical manifestations of beta-thalassemia?

M. Hentze, A. Kulozik, J. Enssle, 1995, Nucleic acids research.

An active foamy virus integrase is required for virus replication.

M. Schweizer, A. Rethwilm, J. Enssle, 1999, The Journal of general virology.

Characterization of a cis-Acting Sequence in the pol Region Required To Transfer Human Foamy Virus Vectors

D. Lindemann, A. Rethwilm, J. Enssle, 1998, Journal of Virology.

Characterization of a cis-Acting Sequence in the pol Region Required To Transfer Human Foamy Virus Vectors

D. Lindemann, A. Rethwilm, J. Enssle, 1998, Journal of Virology.

Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA.

A. Rethwilm, J. Enssle, I. Jordan, 1996, Virology.

Replication of a foamy virus mutant with a constitutively active U3 promoter and deleted accessory genes.

A. Rethwilm, J. Enssle, N. Fischer, 1999, The Journal of general virology.

Characterization of human foamy virus proteins expressed by recombinant vaccinia viruses.

A. Rethwilm, J. Enssle, N. Fischer, 1997, AIDS research and human retroviruses.

Foamy virus reverse transcriptase is expressed independently from the Gag protein.

A. Rethwilm, J. Enssle, I. Jordan, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle

A. Rethwilm, J. Enssle, N. Fischer, 1997, Journal of virology.

Human foamy virus reverse transcription that occurs late in the viral replication cycle

P. Bieniasz, D. Lindemann, M. Bock, 1997, Journal of virology.

Determination of mRNA fate by different RNA polymerase II promoters.

M. Hentze, A. Kulozik, J. Enssle, 1993, Proceedings of the National Academy of Sciences of the United States of America.